Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.43B |
| 2 |
Qualcomm
QCOM
|
+$478M |
| 3 |
Oracle
ORCL
|
+$385M |
| 4 |
CELG
Celgene Corp
CELG
|
+$343M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$308M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.12B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$781M |
| 3 |
Energy Transfer Partners
ET
|
+$384M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.83% |
| 2 | Financials | 5.79% |
| 3 | Healthcare | 5.06% |
| 4 | Consumer Discretionary | 4.03% |
| 5 | Industrials | 3.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Ligand Pharmaceuticals
LGND
$6.02B
| $1.65M | ﹤0.01% |
23,200
-9,041
| -28% | -$666K |
|
3027
PUT
Sonos
SONO
$1.83B
| $1.65M | ﹤0.01% |
145,800
+34,400
| +31% | +$378K |
|
|
RARX
3028
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.65M | ﹤0.01% |
54,969
+51,260
| +1,382% | +$1.17M |
|
3029
Akebia Therapeutics
AKBA
$256M
| $1.65M | ﹤0.01% |
341,212
+302,319
| +777% | +$1.72M |
|
|
DBD
3030
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.65M | ﹤0.01% |
180,276
+148,924
| +475% | +$1.55M |
|
3031
Molina Healthcare
MOH
$10B
| $1.65M | ﹤0.01% |
11,518
-11,337
| -50% | -$1.55M |
|
3032
CALL
Consolidated Edison
ED
$40.2B
| $1.65M | ﹤0.01% |
18,800
-800
| -4% | -$68.9K |
|
3033
Insperity
NSP
$1.96B
| $1.65M | ﹤0.01% |
13,480
-1,149
| -8% | -$138K |
|
3034
PUT
Galicia Financial Group
GGAL
$7.51B
| $1.64M | ﹤0.01% |
46,200
+44,700
| +2,980% | +$1.2M |
|
3035
iShares Latin America 40 ETF
ILF
$3.8B
| $1.64M | ﹤0.01% |
48,555
-197,312
| -80% | -$6.52M |
|
3036
Murphy USA
MUSA
$9.9B
| $1.64M | ﹤0.01% |
19,500
-5,858
| -23% | -$490K |
|
|
ONIT
3037
Onity Group
ONIT
$311M
| $1.64M | ﹤0.01% |
52,727
+143
| +0.3% | +$3.82K |
|
3038
PUT
Zillow
ZG
$7.72B
| $1.63M | ﹤0.01% |
35,700
+8,100
| +29% | +$318K |
|
3039
PUT
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.5B
| $1.63M | ﹤0.01% |
89,400
+4,900
| +6% | +$75.4K |
|
3040
Pinnacle Financial Partners Inc
PNFP
$16.1B
| $1.63M | ﹤0.01% |
28,307
+24,161
| +583% | +$1.36M |
|
|
GWB
3041
DELISTED
Great Western Bancorp, Inc.
GWB
| $1.62M | ﹤0.01% |
45,455
+5,911
| +15% | +$199K |
|
3042
ESCO Technologies
ESE
$8.5B
| $1.62M | ﹤0.01% |
19,637
+3,991
| +26% | +$293K |
|
3043
PUT
Gen Digital
GEN
$16.8B
| $1.62M | ﹤0.01% |
74,400
-5,700
| -7% | -$123K |
|
|
GBT
3044
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.61M | ﹤0.01% |
30,700
+18,700
| +156% | +$1.07M |
|
3045
iShares Morningstar US Equity ETF
ILCB
$1.31B
| $1.61M | ﹤0.01% |
39,064
-1,996
| -5% | -$81.6K |
|
3046
Ollie's Bargain Outlet
OLLI
$4.71B
| $1.61M | ﹤0.01% |
18,519
-1,879
| -9% | -$177K |
|
3047
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$256M
| $1.61M | ﹤0.01% |
60,295
-7,110
| -11% | -$190K |
|
3048
CALL
Edison International
EIX
$25.9B
| $1.61M | ﹤0.01% |
23,900
-142,000
| -86% | -$8.82M |
|
3049
iShares Morningstar Mid-Cap ETF
IMCB
$1.69B
| $1.61M | ﹤0.01% |
33,228
-1,836
| -5% | -$87.9K |
|
3050
Crocs
CROX
$6.43B
| $1.61M | ﹤0.01% |
81,512
+30,047
| +58% | +$696K |
|
Similar funds
Citigroup's Q2 2019 Portfolio in Review
As of Q2 2019, Citigroup held 8,008 positions worth $124B, up 19% from $104B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup deployed $16.7B of net new capital in Q2 2019, opening 295 new positions and adding to 4,221 existing holdings. Its largest new stake was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.
By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 5.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.12B trimmed.
- Citigroup's largest Q2 2019 buy was Invesco Russell 1000 Dynamic Multifactor ETF: 5,950,000 shares worth $177M.
- Citigroup added most to iShares Russell 1000 Value ETF in Q2 2019, an estimated $2.43B increase.
- Citigroup's biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.12B.
- Citigroup fully exited Integrated Device Technology I in Q2 2019, selling an estimated $126M.
- Citigroup's ten largest holdings make up 21% of its $124B portfolio in Q2 2019.
- Citigroup opened 295 new positions and closed 217 in Q2 2019.
- Citigroup's portfolio value rose 19% quarter-over-quarter to $124B.
Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.